This website provides notice to the public that certain Neurotherapeutix products and services are covered by one or more U.S. Patents, and is intended to satisfy the virtual patent marking provisions of 35 U.S.C. § 287. The information provided herein is updated periodically, and other Neurotherapeutix products and services not listed here may also be protected by one or more patents in US and/or foreign jurisdictions.

• U.S. Patent No. 11,900,603 — rsfMRI brain mapping; personalized TMS therapy
• U.S. Patent No. 12,322,102 — rsfMRI and dMRI brain mapping; personalized TMS therapy